{
    "Trade/Device Name(s)": [
        "ONLINE TDM Tobramycin"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K060853",
    "Predicate Device Reference 510(k) Number(s)": [
        "K964457"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KLB"
    ],
    "Summary Letter Date": "June 9, 2006",
    "Summary Letter Received Date": "March 29, 2006",
    "Submission Date": "March 28, 2006",
    "Regulation Number(s)": [
        "21CFR862.3900"
    ],
    "Regulation Name(s)": [
        "Tobramycin test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Tobramycin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche Hitachi 911",
        "Roche Hitachi 912",
        "Roche Hitachi 917",
        "Modular P analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Radioimmunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Roche ONLINE TDM Tobramycin radioimmunoassay for quantification of tobramycin in human serum and plasma on Roche automated chemistry analyzers",
    "Indications for Use Summary": "Intended to measure tobramycin in human plasma and serum for diagnosis and treatment of overdose and monitoring levels to ensure appropriate therapy",
    "fda_folder": "Toxicology"
}